Behçet's disease historical perspective
|
Behçet's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Behçet's disease historical perspective On the Web |
|
American Roentgen Ray Society Images of Behçet's disease historical perspective |
|
Risk calculators and risk factors for Behçet's disease historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]Mahda Alihashemi M.D. [3]Dheeraj Makkar, M.D.[4]
Overview
Behcet disease was first discovered by Hippocrates in the 5th century. In 1937, Hulusi Behçet, Turkish dermatologist described behcet syndrome that genital ulcerations, uveitis, and aphthous ulcers are it's major presentations.
Historical Perspective
Discovery
- Behcet disease was first discovered by Hippocrates in the 5th century.[1]
- In 1937, Hulusi Behçet, Turkish dermatologist described behcet syndrome that genital ulcerations, uveitis, and aphthous ulcers are it's major presentations.[2]
- Geographic origins: Behçet’s syndrome historically occurred in regions along the ancient Silk Road, which stretched from the Mediterranean through the Middle East to East Asia. This geographic distribution has shaped the understanding of its epidemiology
.
Prevalence patterns: The highest prevalence has been reported in Turkey (420 per 100,000 persons), with decreasing frequency toward Northern Europe and the United States. Migration studies also highlighted that immigrants from high-prevalence regions carry increased—but still lower than native—risks .
Recognition as a syndrome: Over the last 20 years, several discoveries have reshaped the understanding of Behçet’s disease. It has shifted from being considered a clinical curiosity to being classified as a primary systemic vasculitis affecting veins and arteries of all sizes. This change reflects the broader spectrum of signs and symptoms recognized and the prognostic implications for patients .
Early genetic insights: The first genetic association identified was with HLA-B*51, discovered decades ago. Later, genome-wide association studies and sequencing technologies revealed multiple additional genes, leading to new classification schemes and insights into immune dysregulation .
Evolution of classification criteria: Diagnostic and classification approaches have evolved—from the 1990 International Study Group (ISG) criteria, which required recurrent oral ulcers plus two additional findings, to the 2014 International Criteria for Behçet’s Disease (ICBD), which introduced a point-based system incorporating neurologic and vascular involvement. These refinements reflect recognition of the disease’s multisystemic nature .
References
- ↑ FEIGENBAUM A (1956). "Description of Behçet's syndrome in the Hippocratic third book of endemic diseases". Br J Ophthalmol. 40 (6): 355–7. PMC 509495. PMID 13355940.
- ↑ Mutlu S, Scully C (1994). "The person behind the eponym: Hulûsi Behçet (1889-1948)". J Oral Pathol Med. 23 (7): 289–90. PMID 7965882.